» Articles » PMID: 21106527

Disruption of the Acyl-CoA-binding Protein Gene Delays Hepatic Adaptation to Metabolic Changes at Weaning

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Nov 26
PMID 21106527
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor is an intracellular protein that binds C(14)-C(22) acyl-CoA esters and is thought to act as an acyl-CoA transporter. In vitro analyses have indicated that ACBP can transport acyl-CoA esters between different enzymatic systems; however, little is known about the in vivo function in mammalian cells. We have generated mice with targeted disruption of ACBP (ACBP(-/-)). These mice are viable and fertile and develop normally. However, around weaning, the ACBP(-/-) mice go through a crisis with overall weakness and a slightly decreased growth rate. Using microarray analysis, we show that the liver of ACBP(-/-) mice displays a significantly delayed adaptation to weaning with late induction of target genes of the sterol regulatory element-binding protein (SREBP) family. As a result, hepatic de novo cholesterogenesis is decreased at weaning. The delayed induction of SREBP target genes around weaning is caused by a compromised processing and decreased expression of SREBP precursors, leading to reduced binding of SREBP to target sites in chromatin. In conclusion, lack of ACBP interferes with the normal metabolic adaptation to weaning and leads to delayed induction of the lipogenic gene program in the liver.

Citing Articles

Acyl coenzyme A binding protein (ACBP): An aging- and disease-relevant "autophagy checkpoint".

Montegut L, Abdellatif M, Motino O, Madeo F, Martins I, Quesada V Aging Cell. 2023; 22(9):e13910.

PMID: 37357988 PMC: 10497816. DOI: 10.1111/acel.13910.


From benzodiazepines to fatty acids and beyond: revisiting the role of ACBP/DBI.

Alquier T, Christian-Hinman C, Alfonso J, Faergeman N Trends Endocrinol Metab. 2021; 32(11):890-903.

PMID: 34565656 PMC: 8785413. DOI: 10.1016/j.tem.2021.08.009.


The Gliopeptide ODN, a Ligand for the Benzodiazepine Site of GABA Receptors, Boosts Functional Recovery after Stroke.

Lamtahri R, Hazime M, Gowing E, Nagaraja R, Maucotel J, Alasoadura M J Neurosci. 2021; 41(33):7148-7159.

PMID: 34210784 PMC: 8372017. DOI: 10.1523/JNEUROSCI.2255-20.2021.


Advances in Understanding the Acyl-CoA-Binding Protein in Plants, Mammals, Yeast, and Filamentous Fungi.

Qiu S, Zeng B J Fungi (Basel). 2020; 6(1).

PMID: 32164164 PMC: 7151191. DOI: 10.3390/jof6010034.


Differential impacts on multiple forms of spatial and contextual memory in diazepam binding inhibitor knockout mice.

Ujjainwala A, Courtney C, Wojnowski N, Rhodes J, Christian C J Neurosci Res. 2019; 97(6):683-697.

PMID: 30680776 PMC: 6449197. DOI: 10.1002/jnr.24393.


References
1.
Neess D, Kiilerich P, Sandberg M, Helledie T, Nielsen R, Mandrup S . ACBP--a PPAR and SREBP modulated housekeeping gene. Mol Cell Biochem. 2006; 284(1-2):149-57. DOI: 10.1007/s11010-005-9039-9. View

2.
Lee P, Liu P, Li W, DeBose-Boyd R . Amplification of the gene for SCAP, coupled with Insig-1 deficiency, confers sterol resistance in mutant Chinese hamster ovary cells. J Lipid Res. 2007; 48(9):1944-54. DOI: 10.1194/jlr.M700225-JLR200. View

3.
Horton J, Shah N, Warrington J, Anderson N, Park S, Brown M . Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A. 2003; 100(21):12027-32. PMC: 218707. DOI: 10.1073/pnas.1534923100. View

4.
Cole T, WILCOX H, Heimberg M . Effects of adrenalectomy and dexamethasone on hepatic lipid metabolism. J Lipid Res. 1982; 23(1):81-91. View

5.
Bobard A, Hainault I, Ferre P, Foufelle F, Bossard P . Differential regulation of sterol regulatory element-binding protein 1c transcriptional activity by insulin and liver X receptor during liver development. J Biol Chem. 2004; 280(1):199-206. DOI: 10.1074/jbc.M406522200. View